MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,542,544 | +580.0% | 131,400 | +352.7% | 0.01% | +450.0% |
Q3 2022 | $521,000 | +129.5% | 29,026 | +70.5% | 0.00% | +100.0% |
Q1 2022 | $227,000 | -77.6% | 17,022 | -62.3% | 0.00% | -50.0% |
Q3 2021 | $1,013,000 | +33.1% | 45,136 | +22.0% | 0.00% | 0.0% |
Q1 2021 | $761,000 | +3.3% | 36,997 | +38.7% | 0.00% | 0.0% |
Q4 2020 | $737,000 | +120.0% | 26,668 | +12.0% | 0.00% | +100.0% |
Q3 2020 | $335,000 | -89.5% | 23,816 | -84.7% | 0.00% | -93.8% |
Q2 2020 | $3,202,000 | +102.9% | 155,266 | -25.7% | 0.02% | +23.1% |
Q1 2020 | $1,578,000 | +77.3% | 208,976 | +264.4% | 0.01% | +333.3% |
Q4 2019 | $890,000 | +153.6% | 57,343 | -15.0% | 0.00% | +200.0% |
Q3 2019 | $351,000 | -35.4% | 67,473 | +12.5% | 0.00% | -50.0% |
Q2 2019 | $543,000 | +168.8% | 60,000 | +690.2% | 0.00% | +100.0% |
Q3 2018 | $202,000 | – | 7,593 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |